It is known that 8-arginine vasopressin (AVP) and its analogue 1-deamino-8-D-arginine vasopressin (DDAVP) raise circulating vWF and FVIII levels in physiological conditions, and this is the basis for using desmopressin the management of Haemophilia A and von Willebrand disease.
Therefore, could elevated levels of ADH such as in states of chronic hyperosmolality/volume depletion stimulate and stabilise sufficient circulating factor VIII/vWF levels such that mild variants of Hemophilia A and von Willebrand disease (either congenital or acquired) can be masked?